News
Konvomep Approved for Active Benign Gastric Ulcer, Upper GI Bleed Risk Reduction
Konvomep contains 2mg of omeprazole, a proton pump inhibitor, and 84mg of sodium bicarbonate per mL after reconstitution.
Your search for proton pump inhibitor returned 120 results
News
New Tablet Formulation of Calquence Approved for CLL, SLL, MCL
The approval was based on data from the phase 1 ELEVATE-PLUS trials, which showed the acalabrutinib 100mg tablets were bioequivalent to the acalabrutinib 100mg capsules.
News
Dupixent Gets FDA Approval for Eosinophilic Esophagitis
The approval was based on efficacy and safety data from a phase 3 trial, which included two 24-week treatment periods in patients 12 years of age and older with EoE.
Drugs in the Pipeline
Vonoprazan NDA Submitted for Erosive Esophagitis
The application is supported by data from the pivotal phase 3 PHALCON-EE trial which compared the efficacy and safety of vonoprazan to lansoprazole in patients with erosive esophagitis.
News
PPI Use May Increase Risk of Community-Acquired Pneumonia
Increased incidence of CAP was noted in stroke patients using PPIs.
News
Proton Pump Inhibitor Use Linked to Asthma Risk in Children
Findings showed that children who were initiated on PPIs were 57% more likely to be diagnosed with asthma.
Drugs in the Pipeline
Clinical Program for Investigational GERD Drug Discontinued
The bile acid sequestrant was designed to be maintained in the stomach over an extended period of time where it was expected to intercept bile before it reached the esophagus.
News
Patient’s Hypercalcemia Linked to OTC Antacid Use
A recently published report describes the case of a 61-year-old male patient who experienced antacid-induced hypercalcemia and highlights the importance of performing thorough medication reconciliation.
AAAAI 2020
Prenatal Exposure to Antacids Increases Food Protein-Induced Allergic Proctocolitis Risk
Prenatal exposure to calcium carbonate antacids was associated with the development of food protein-induced allergic proctocolitis, a type of delayed inflammatory gut food allergy to protein, in offspring.
News
Three-Drug Combo Talicia Now Available for H. pylori Infection
Talicia (omeprazole magnesium, amoxicillin and rifabutin delayed-release capsules) has been made available for the treatment of Helicobacter pylori (H. pylori) infection in adults, according to RedHill Biopharma.
